Transport systems for opioid peptides in mammalian tissues

AAPS Journal

Volumn 7, Issue 4, 2005, Pages

  Ganapathy, Vadivel ^a   Miyauchi, Seiji ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Multidrug resistance related protein 2; Opioid peptides; Organic anion transporting polypeptides; P glycoprotein; Peptide transporters; Sodium coupled transporters; Transmembrane transport

Indexed keywords

ALPHA NEOENDORPHIN; ANION TRANSPORT PROTEIN; BETA ENDORPHIN; BETA NEOENDORPHIN; DYNORPHIN A; DYNORPHIN[1-8]; ENDOMORPHIN 1; ENDOMORPHIN 2; GLYCOPROTEIN P; HEPTAPEPTIDE; LEUCINE ENKEPHALIN; METENKEPHALIN; MULTIDRUG RESISTANCE PROTEIN 2; OCTAPEPTIDE; OPIATE PEPTIDE; PEPTIDE TRANSPORTER 1; PROTON; CARRIER PROTEIN; PEPTIDE FRAGMENT; PEPTIDE PERMEASE;

BLOOD BRAIN BARRIER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG TRANSPORT; HUMAN; MOLECULAR CLONING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; AMINO ACID SEQUENCE; ANIMAL; GENETICS; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; OPIOID PEPTIDES; PEPTIDE FRAGMENTS;

EID: 33646664658     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070482     Document Type: Review

References (32)

1. Vaccarino AL, Kastin AJ. Endogenous opiates: 2000. Peptides. 2001;22:2257-2328.
2. Smith QR. A review of blood-brain barrier transport techniques. Methods Mol Med. 2003;89:193-208.
3. Banks WA, Kastin AJ. Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol. 1990;259:E1-E10.
4. Kastin AJ, Fasold MB, Smith RR, Horner KA, Zadina JE. Saturable brain-to-blood transport of endomorphins. Exp Brain Res. 2001; 139:70-75.
5. Somogyvari-Vigh A, Kastin AJ, Liao J, Zadina JE, Pan W. Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells. Exp Brain Res. 2004; 156:224-230.
6. Fiori A, Cardelli P, Negri L, Savi MR, Strom R, Erspamer V. Deltorphin transport across the blood-brain barrier. Proc Natl Acad Sci USA. 1997;94,9469-9474.
7. - -coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat. Biochem J. 2003:375:17-22.
8. Leibach FH, Ganapathy V. Peptide transporters in the intestine and the kidney. Annu Rev Nutr. 1996;16:99-1119.
9. Zhao K, Luo G, Zhao GIVI, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther. 2003:304:425-432.
10. Fujita T, Kishida T, Okada N, Ganapathy V, Leibach FH, Yamamoto A. Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H+/ peptide transporter PEPT2-mediated transport system. Neurosci Lett. 1999;271:117-120.
11. +/Peptide transporter PEPT2. Brain Res. 2004;997:52-61.
12. Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA. 1989:695-698.
13. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest. 1995;96:1698-1705.
14. Thompson SJ, Koszdin K, Bernards CM. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology, 2000;92:1392-1399.
15. King M, Su W, Chang A, Zuckerman A, Pasternak GW. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci. 2001;4:268-274.
16. Jonker JW, Wagenaar E, van Deemter L, et al. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Br J Pharmacol. 1999; 127:43-50.
17. Chen C, Pollack GM. Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-genedeficient mice. J Pharmacol Exp Ther. 1998-287:545-552.
18. Chen C, Pollack GM. Enhanced antinociception of the model opioid pepticle [D-penicillamine] enkephalin by P-glycoprotein modulation, Pharm Res. 1999:16:296-301.
19. Sarkadi B, Muller M, Homolya L, et al. Interaction of bioactive hydrophobic peptides with the human multidrug transporter. FASEBJ. 1994;8:766-770.
20. Oude Elferink RPJ, Zadina J. MDR1 P-glycoprotein transports endogenous opioid peptides. Peptides. 2001;22:2015-2020.
21. Kastin AJ, Fasold MB, Zadina JE, Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system. Drug Metab Dispos. 2002;30:231-234.
22. Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties, Pflugers Arch. 2004,447:653-665.
23. Cattori V, van Montfoort JE, Stieger B, et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 2001:443:188-195.
24. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther. 2000;294:73-79.
25. Kullak-Ublick GA, Ismair MG, Stieger B, et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with 3 other OATPs of human liver. Gastroenterology. 2001;120:525-533.
26. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin. J Pharm Pharmacol. 2003;55:1013-1020.
27. Lee W, Glaeser H, Smith LH, et al. Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1 A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem. 2005;280:9610-9617.
28. Reichel C, Gao B, Van Montfoort J, et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology. 1999;117:688-695.
29. Konig J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000;275:23161-23168
30. Konig J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000;278:G156-G164.
31. Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems. J Pharmacol Exp Ther. 2004:311:1203-1210.
32. Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5] enkephalin. Drug Metab Dispos. 2005;33:287-293.